Call for Papers

Guest editors:  Prof. Zhonggao Gao, Institute of Materia Medica, Beijing, China

Prof. Han Chang Kang, The Catholic University of Korea, Bucheon, Republic of Korea

Article deadline: 15 December 2015

Publishing date: 25 March 2016

 

In this special issue of Functional materials, nanocarriers, and formulations for targeted therapy,

articles describing the current advances on targeted therapies using functional materials, nanocarriers,

and formulations will be invited for submission. It is envisioned that with this Special Issue compilation,

researchers in the field will be able to learn the current advances and gain hints for their future works on

related drug design and development.

 

Manuscripts should be submitted online at http://www.elsevier.com/locate/apsb by registering and

logging in to this website. Papers will be published online continuously (as soon as accepted) and will be

listed together on the special issue website. Research articles, review articles as well as short

communications are invited.

 

Submitted manuscripts should not have been published previously, nor be under consideration for

publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a

peer-review process. A guide for authors and other relevant information for submission of manuscripts

is available on the Instructions for Authors page

(http://yxxb.imm.ac.cn/yxxb_en/EN/column/column79.shtml). Please visit the the page before submitting

a manuscript. Please give an indication of “submission to special issue” when submitting your article.  

 

Brief introduction of APSB:

Acta Pharmaceutica Sinica B (APSB) (ISSN: 2211-3835) is a bimonthly English peer-reviewed online

journal in ScienceDirect, which publishes research articles, reviews and communications in all areas of

pharmaceutical sciences. The journal is co-published by Elsevier B.V., in association with the Institute

of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.

APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology,

pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis,

pharmacokinetics and drug metabolism.

APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953 and is now the

most successful pharmaceutical journal in China. It is the only pharmaceutical journal awarded "China's

top 100 journals " for 8 years, continuously. The editorial office of Acta Pharmaceutica Sinica publishs

the English journal APSB in order to promote the communicatons of pharmaceutical research findings in

the international community.

 

TEL: 86-10-63026192-107

E-mail: liuyin@imm.ac.cn

Acta Pharmaceutica Sinica B